Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q1 2018 · 10-Q
Revenue$7.39B$7.39B+16.7% vs Q1 2017 Net Income$418.00M$418.00M−0.2% vs Q1 2017 EPS Diluted$0.23$0.23−4.2% vs Q1 2017 Gross Profit$3,739,000,000+35.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flow$1,108,000,000+93.0% Free Cash Flowderived$833,000,000+175.8% Margins · derivedGross margin50.6%+7.2 pt vs Q1 2017
Operating margin8.2%+12.0 pt vs Q1 2017
Net margin5.7%−1.0 pt vs Q1 2017
ended Mar 31, 2018 · filed May 2, 2018 · 32 d after period end